Daniel Sjöberg

Daniel Schulz-Jander is an accomplished professional with extensive experience in analytical chemistry and leadership roles in the pharmaceuticals and biotechnology sectors. Currently serving as Sr. Director at QPS Netherlands B.V. since February 2022, Daniel previously held key positions at Frontage Laboratories, Inc. as Site & Lab Head for Bioanalytical and Biologics Services, and spent over 16 years at Medtronic in various roles culminating as Distinguished Scientist. Daniel's expertise includes strategic leadership in drug development, regulatory affairs, and analytical chemistry, with a strong focus on drug combination products and bioanalytical capabilities. Daniel possesses a Doctorate in Analytical Chemistry from the Technical University of Munich, complemented by a PostDoctoral Research in Small Molecule Metabolism from the University of California, Berkeley, and degrees in Analytical Chemistry and Chemistry from the University of Kassel.